These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2738264)

  • 1. Cardioprotective effects of various class I antiarrhythmic drugs in canine hearts.
    Hanaki Y; Sugiyama S; Hieda N; Taki K; Hayashi H; Ozawa T
    J Am Coll Cardiol; 1989 Jul; 14(1):219-24. PubMed ID: 2738264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of flecainide on 2 hour occlusion-induced myocardial damages in dog].
    Sugiyama S; Hieda N; Ozawa T; Fukushima A; Ogawa T; Hanaki Y
    Kokyu To Junkan; 1989 Apr; 37(4):443-7. PubMed ID: 2500690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of bepridil on ischemic myocardial damages in dogs.
    Hanaki Y; Sugiyama S; Hieda N; Taki K; Ozawa T
    Arch Int Pharmacodyn Ther; 1989; 299():221-31. PubMed ID: 2789024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts.
    Sano T; Sugiyama S; Taki K; Hanaki Y; Shimada Y; Ozawa T
    Br J Pharmacol; 1990 Mar; 99(3):577-81. PubMed ID: 2331583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and antiarrhythmic effects of three calcium channel antagonists in ischemic canine hearts.
    Ito T; Ogawa T; Satake T; Hieda N; Sugiyama S; Ozawa T
    Clin Ther; 1989; 11(4):461-71. PubMed ID: 2776164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
    Ogawa T; Hieda N; Sugiyama S; Ito T; Satake T; Ozawa T
    Heart Vessels; 1989; 5(1):10-6. PubMed ID: 2573596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts.
    Ogawa T; Hieda N; Sugiyama S; Toki Y; Ito T; Ogawa K; Satake T; Ozawa T
    Arzneimittelforschung; 1988 Feb; 38(2):228-30. PubMed ID: 3370069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cibenzoline on myocardial damages in dogs.
    Taki K; Sugiyama S; Hieda N; Hanaki Y; Sano T; Shimada Y; Ozawa T
    Arzneimittelforschung; 1989 Mar; 39(3):325-8. PubMed ID: 2757658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
    Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
    Hashimoto K; Shibuya T; Satoh H; Imai S
    Jpn Circ J; 1983 Jan; 47(1):92-7. PubMed ID: 6827775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and morphological changes in myocardium during coronary occlusion and reperfusion in canine hearts: effects of propranolol on myocardial damage.
    Ogawa T; Sugiyama S; Hieda N; Ito T; Satake T; Ozawa T
    Cardiovasc Res; 1989 May; 23(5):417-23. PubMed ID: 2611809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide.
    Komori S; Sano S; Li BH; Matsumura K; Naitoh A; Mochizuki S; Ishihara T; Watanabe A; Umetani K; Ijiri H
    Heart Vessels; 1995; 10(1):7-11. PubMed ID: 7537263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency dependent effects of class I antiarrhythmic agents studied in patients with implanted pacemakers.
    Takanaka C; Lee JK; Nonokawa M; Sugiyama T; Yame S
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2100-5. PubMed ID: 7845825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
    Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
    Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.